February 2014 Newsletter

February 19, 2014:

Glaucoma Surgeries Decline in Fourth Quarter as Brutal Winter Disrupts Patient Care

At the same time, the number of patients being treated for glaucoma grew at an estimated 3.8 percent, according to Market Scope’s latest survey of glaucoma specialists.

February 19, 2014:

Road to FDA Approval Filled with Challenges for STAAR’s Toric Phakic IOL

An FDA advisory panel meeting to review the lens will be rescheduled after a wintry mix forced cancellation on February 14.

February 19, 2014:

IOL Options for Treating Presbyopia Expected to Grow, Drive Sales over Next Five Years

In 2004, there were less than 50,000 multifocal IOLs implanted globally. We project the number in 2014 will reach well over 600 thousand.

February 19, 2014:

Ellex May Revitalize iScience Canaloplasty Business

Ellex’ resources may expand sales of iScience’s iTrack 250 microcatheter, which is used in canaloplasty procedures for the treatment of glaucoma.

February 19, 2014:

Demand for Disposable Instruments Fuels Growth in the Global Ophthalmic Surgical Instruments Market

Globally, the market is expected to approach $1.0 billion in 2014 and nearly $1.25 billion in 2019 at a compounded annual growth rate of 5 percent.

February 19, 2014:

February 2014 News Briefs

Social media